MARKSANS PHARMA
Back to Balance Sheet
|
MARKSANS PHARMA Last 5 Year Contingent Liabilities History
[Consolidated]
| Mar2025 | Mar2024 | Mar2023 | Mar2022 | Mar2021 | |
|---|---|---|---|---|---|
| Contingent Liabilities | - | - | ₹1.45 Cr | ₹1.45 Cr | ₹20 Cr |
What is the latest Contingent Liabilities ratio of MARKSANS PHARMA ?
| Year | Contingent Liabilities |
|---|---|
| Mar2025 | - |
| Mar2024 | - |
| Mar2023 | ₹1.45 Cr |
| Mar2022 | ₹1.45 Cr |
| Mar2021 | ₹20 Cr |
How is Contingent Liabilities of MARKSANS PHARMA Trending?
| Years | Contingent Liabilities | % Change | |
|---|---|---|---|
| Mar2025 | - | 0 | |
| Mar2024 | - | -100.00 | |
| Mar2023 | ₹1.45 Cr | 0.00 | |
| Mar2022 | ₹1.45 Cr | -92.68 | |
| Mar2021 | ₹20 Cr | - | |
Compare Contingent Liabilities of peers of MARKSANS PHARMA
| Peers & Returns | Market Capitalization | 1 Week | 1 Month | 1 Year | ||
| MARKSANS PHARMA | ₹7,693.1 Cr | 3% | -6.2% | -15.5% | Stock Analytics | |
| SUN PHARMACEUTICAL INDUSTRIES | ₹426,470.0 Cr | -0.3% | 3.1% | 2.2% | Stock Analytics | |
| DIVIS LABORATORIES | ₹161,996.0 Cr | 0.5% | -2.9% | 5.4% | Stock Analytics | |
| TORRENT PHARMACEUTICALS | ₹144,440.0 Cr | 0.1% | 1.4% | 37.6% | Stock Analytics | |
| DR REDDYS LABORATORIES | ₹108,417.0 Cr | 1.9% | 1.4% | 10.7% | Stock Analytics | |
| CIPLA | ₹101,445.0 Cr | -3.3% | -6.9% | -17% | Stock Analytics | |
MARKSANS PHARMA Share Price vs Sensex
| Share Price Returns(%) | 1 Week | 1 Month | 1 Year |
| MARKSANS PHARMA | 3% |
-6.2% |
-15.5% |
| SENSEX | -0% |
-10.7% |
1% |
You may also like the below Video Courses